Wedbush maintained its Outperform rating on Palantir (PLTR) after the company was awarded a $795M U.S. Army modification to contract for Maven Smart System.
Modiv Industrial (MDV) said it was seeking shareholder approval for a reverse stock split to address the cost issue associated with dormant accounts, and the process will be followed with a forward split if implemented.
Biopharmaceutical company Outlook Therapeutics (OTLK) priced an underwritten public offering of ~9.29M shares with accompanying warrants to purchase ~18.57M shares. The combined public offering price of common stock and accompanying warrant is $1.40.